August 11th 2025
NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.
How Avicenna Recognized Melancholia and Mixed States—1000 Years Before Modern Psychiatry
September 22nd 2020Avicenna may have been among the first physicians to document that anger is often a transitional state from melancholic depression to mania—implicitly recognizing the “switch” phenomenon.
Read More
Finding Meaning in the Face of Suffering
An added component of cancer treatment is discovering what is most meaningful in the patient’s life and using that to buoy them during difficult moments. That, in a nutshell, is the psychiatrist's role.
Read More
Psychoanalysis and the Re-Enchantment of Psychiatry: Jonathan Shedler, PhD
July 29th 2020In this interview, Dr Aftab and Dr Shedler discuss the relationship between the psychoanalytic worldview and the medical model, and they reexamine the role of psychodynamic psychotherapy in contemporary psychiatry and psychology.
Read More
Convergence Mental Health: A New Pathway for Transdisciplinary Innovation and Entrepreneurship
A paradigm shift is needed in order to solve the unprecedented complexities and challenges associated with the current global mental health crisis.
Read More